Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT06471114
NCT06471114Active, not recruitingNot Applicable

Evaluation of the Efficacy of Systemic Treatments for Alopecia

University Hospital, Brest1 site in 1 country250 target enrollmentStarted: November 1, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
250
Locations
1
Primary Endpoint
Short-term efficacy and security of systemic treatments
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim of our study was to retrospectively assess the efficacy and safety of systemic treatments in patients with alopecia areata, by recruiting cases from the HUGO network (Hôpitaux Universitaires du Grand Ouest), a network of 5 hospitals : Brest, Nantes, Rennes, Angers and Tours.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patient with severe alopecia
  • •Has received at least one systemic treatment for at least 3 months (among methotrexate, intravenous or oral corticosteroid therapy, Ciclosporin, UVA/UVB phototherapy)
  • •Patient affiliated to a social security scheme
  • •Age greater than or equal to 18 years

Exclusion Criteria

  • •Patients under legal protection (guardianship, curatorship, etc.)
  • •Refusal to participate
  • •Other cause of alopecia
  • •Follow-up less than 3 months
  • •Age under 18 years

Outcomes

Primary Outcomes

Short-term efficacy and security of systemic treatments

Time Frame: From January 2010 to December 2020

Response rates including complete response or partial response or no response for each modality of treatment. and Side effects rate

Secondary Outcomes

  • Long-term efficacy of systemic treatments(From January 2010 to December 2020)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 2
Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)Prostate Cancer
NCT01751438M.D. Anderson Cancer Center180
Completed
Phase 2
Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic PeriodontitisChronic Periodontitis
NCT02013323Government Dental College and Research Institute, Bangalore60
Completed
Not Applicable
Efficacy and Tolerability of Venoactive Drugs in Patients With Chronic Venous Diseases C4a&b in Real Clinical Practice.Chronic Venous Diseases
NCT04138576Servier Russia381
Completed
Not Applicable
Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal OsteoporosisOsteoporosis, PostmenopausalOsteoporotic Fractures
NCT04748029Ufuk University139
Recruiting
Not Applicable
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort StudyCoronary Artery StenosisCoronary Artery RestenosisCoronary Artery Disease ProgressionInflammationInflammatory DiseaseInflammation VascularCoronary Artery Disease
NCT05860400Peking Union Medical College Hospital39